Research analysts at TD Cowen began coverage on shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The firm set a “buy” rating on the stock.
Tectonic Therapeutic Price Performance
Recommended Stories
- Five stocks we like better than Tectonic Therapeutic
- Upcoming IPO Stock Lockup Period, Explained
- Risk Tolerance vs Risk Capacity: Key Differences & How to Measure
- How to Capture the Benefits of Dividend Increases
- Ciena Stock: Powering the AI Boom – A Network Infrastructure Play
- Ride Out The Recession With These Dividend Kings
- Is NVIDIA Stock Done Playing With the Market? Buy, Sell, or Hold
Receive News & Ratings for Tectonic Therapeutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tectonic Therapeutic and related companies with MarketBeat.com's FREE daily email newsletter.
